Developing an Integrative, Recovery-Based, Post-Acute COVID-19 Syndrome (PACS) Psychotherapeutic Intervention
Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Jul 8, 2022
Trial Information
Current as of June 06, 2025
Completed
Keywords
ClinConnect Summary
Epidemiological estimates suggest that approximately 11,390,400 Americans, and 90,300 Veterans in VA care experience symptoms for months after initial COVID-19 infection, a phenomenon known as Post-Acute COVID-19 Syndrome (PACS) or Long COVID. Common symptoms of Long COVID include prolonged fatigue, impairment of memory, concentration disorder, headache, pain, insomnia, anxiety, post-traumatic stress disorder (PTSD), and depression (Taquet et al., 2021). Longer term effects of COVID-19 have been reported in all age groups and demographics including persons with asymptomatic, mild, or severe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. U.S. Veteran
- • 2. Ages 18-80
- • 3. Positive screen for Long COVID (e.g. COVID-19 positive, diagnosed with a PCR test, an antibodies blood test, and or a diagnosis by a physician at the JJPVAMC Long COVID Clinic and symptoms lasting 1 month or longer after infection)
- • 4. Participation in VA services at the JJPVAMC
- • 5. Sufficient clinical stability and readiness to participate in group therapy as deemed by their VA service provider
- Exclusion Criteria:
- • 1. Active alcohol or opiate dependence requiring medically supervised withdrawal
- • 2. Active psychosis
- • 3. MINI Mental Status \< 23 or inability to function in a group setting
- • 4. Unable to operate telehealth platforms or other electronic devices
- • 5. Non-English speaking
- • 6. Lack of capacity to consent
- • 7. Unable or unwilling to provide at least one contact for emergency purposes
About Va Office Of Research And Development
The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bronx, New York, United States
Bronx, New York, United States
Patients applied
Trial Officials
Marianne S. Goodman, MD
Principal Investigator
James J. Peters Veterans Affairs Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials